More broadly, such statements misleadingly imply that the company’s cardiovascular disease and osteoporosis screening package saves lives and prevent strokes and cardiovascular disease when used in unselected, asymptomatic individuals in the general population age of 50 or older, regardless of their cardiovascular or osteoporosis risk factor profiles, which is the very consumer population targeted by Life Line Screening.” “These statements claim that Life Line Screening’s package of cardiovascular disease and osteoporosis screening tests have helped save thousands of lives since 1993 and prevent strokes and other types of cardiovascular disease. “The most egregious claims in this regard are those explicitly stating or strongly implying that the package of cardiovascular disease and osteoporosis screening tests offered by the company saves lives, improve health, and prevent strokes and other cardiovascular diseases,” the letter states. While Life Line Screening maintains that a physician reviews each screening and the results are sent to customers detailing their risk categories, Public Citizen claims that the company overstates the use of such tests and does not follow current medical guidelines. “These materials make unsubstantiated medical-benefit efficacy claims about Life Line Screening’s cardiovascular disease and osteoporosis screening package and omit information material to consumers regarding the risk of adverse health-related outcomes and financial harms that may result from this indiscriminate screening.” “There is evidence that the company’s advertising and promotional materials contain numerous statements that may be deceptive within the meaning of the Federal Trade Commission Act,” the letter states.
0 kommentar(er)
